Vasudevan Lab

Cancer signaling, (single cell) genomics, and functional genetics, with an emphasis on better diagnostic tests and treatments for neurofibromatosis.

[Vasudevan Lab @VasuLabUCSF]

Delighted to host the first annual @VasuLabUCSF holiday party - grateful to work with these people every day.

[UCSF Radiation Oncology @UCSFRadOnc]

Exciting new paper by @VasuLabUCSF et al! "IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors" https://t.co/oiTIe6qMfw @NeurosurgUCSF @UCSFHospitals

[Journal of Clinical Investigation @jclinicalinvest]

This study is directly relevant to the clinical care of patients with the most common malignant tumor of the peripheral nervous system, while providing fundamental biological insight👇

Harish N. Vasudevan @VasuLabUCSF & team @UCSF reveal transcriptional, functional genetic, and cellular mechanisms of interferon signaling that underlie radiotherapy response in people with #MPNST: https://t.co/MTZBGbcENY

[JCI insight @JCI_insight]

NF1 is frequently mutated in #glioblastoma, yet therapies targeting this alteration often fall short.

@VasuLabUCSF & team @UCSF now show NF1 mutant glioblastomas exhibit prognostic signatures with distinct sensitivity to MEK inhibition: https://t.co/FRfozC2Arh

[Vasudevan Lab @VasuLabUCSF]

Excellent time giving grand rounds last week @UMRogelCancer with old friends @gouthamnarla and new ones @castro2355_mg @UCSFCancer @NeurosurgUCSF

[Vasudevan Lab @VasuLabUCSF]

Happy 4th of July - to celebrate, we asked if there is meaningful heterogeneity within somatic NF1 mutant glioblastomas? We think so https://t.co/LWwT0hcY2T As always, appreciate everyone that made this work possible @NeurosurgUCSF @UCSFCancer @ntapresearch @ChildrensTumor

[Neurofibromatosis Therapeutic Acceleration Program @ntapresearch]

A delightful time catching up with 10 of NTAP’s 18 Francis S. Collins Scholars & their mentors while in Brussels @ChildrensTumor. Thank you all for your dedication to moving the needle in NF1 research! #NFCON24 #endNF

[Vasudevan Lab @VasuLabUCSF]

Sunrise-ish run through brussels - enjoying every part of the annual @ChildrensTumor meeting #nfcon24 with friends from @NeurosurgUCSF @ntapresearch

[Vasudevan Lab @VasuLabUCSF]

Excited that our DoD New Investigator Award (https://t.co/lX54TSeRJu) is officially funded - thanks to everyone that helped make this happen @CDMRP @domespo @simanshu and time to get to work!

[Vasudevan Lab @VasuLabUCSF]

A pleasure to review the therapeutic landscape for NF-1 with my future colleague @bnamd87 https://t.co/F9k2RwaKVO

[UCSF Neurosurgery @NeurosurgUCSF]

Additionally, in a study led by @VasuLabUCSF & @LabRaleigh, researchers demonstrate how NF-1 mutant Schwann cell tumors undergo malignant transformation, identifying new potential strategies against treatment resistance: https://t.co/O3NAcgFWGq @UCSFCancer #neurofibromatosis

[Nature Communications @NatureComms]

New featured image on our homepage!
https://t.co/q0mdqcGp64

3 papers on schwannomas, tumors of the nervous system derived from Schwann cells

@VasuLabUCSF @LabRaleigh @sjohnliu
#CancerResearch @NatResCancer

https://t.co/VrOAa1FWVQ
https://t.co/jHOddAQaKR
https://t.co/Gdu8UofjTG

[Vasudevan Lab @VasuLabUCSF]

Very proud of @LexiHaugh for her analysis of targeted DNA sequencing in cutaneous melanoma: https://t.co/1Ns9QeEl9L
@ad1600

[Vasudevan Lab @VasuLabUCSF]

Delighted to share that our work looking at functional interactions between neurofibromatosis tumor suppressors is officially accepted: https://t.co/xpgCi5CzVh

[Neurofibromatosis Therapeutic Acceleration Program @ntapresearch]

Looking forward to #SNO2023 presentation by #FrancisSCollinsScholar @VasuLabUCSF presenting innovative approaches to targeting NF1 loss in nervous system tumors
@NeuroOnc
@NTAPresearch @HopkinsMedicine #NF

[Vasudevan Lab @VasuLabUCSF]

Our manuscript investigating bulk and single cell genomics of melanoma brain metastases is now online! Many thanks to everyone that made this work possible https://t.co/y1ITy0Fzim

[The Pike Lab @pike_lab]

So pleased to see our work in @NatureComms, led by
@SkakodubAnna, @hswalch, and @KathrynTringale, with @nikolausschultz, describing the genomics and clinical outcomes of a large set of patients with NSCLC brain metastasis. @MSKCancerCenter @MSK_RadOnc
https://t.co/4Dm0Y1WVpf

[Vasudevan Lab @VasuLabUCSF]

Big congratulations to @LexiHaugh on her ASCO YIA! Excited to make some progress on (NF1 mutant) metastatic melanoma

[Vasudevan Lab @VasuLabUCSF]

The Vasudevan Lab makes its first twitter post: Excited to share our preprint looking at functional interactions between NF tumor suppressors https://t.co/eKTVULnyZd